?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
173 Unternehmen gefunden • Seite 3 von 7
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Fennec Pharmaceuticals Inc | 50.0 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 6.44 | 8.98 | ▲ 204.69% | ▼ -11.66% | - | - | - | -21.82% | ▲ 2190.74% | -14.22% | ▲ 2172.04% | -27.94% | ▲ 1790.91% | 1 / 9 | −5,10 | −1,7-fach | 58 / 100 | 3,9 / 100 | −0,84 |
![]() | Liquidia Technologies Inc | 49.2 | Arzneimittel (Pharmazeutisch) | USA | 4.0 Mrd. USD | 29.05 | 66.55 | 8.93 | 20.64 | ▲ 192.49% | ▲ 2.89% | - | - | - | -43.53% | ▼ -22.33% | -32.45% | ▼ -16.23% | -25.28% | ▼ -3.90% | 5 / 9 | −5,88 | −5,5-fach | 44 / 100 | −10,1 / 100 | 6,03 |
![]() | Madrigal Pharmaceuticals Inc | 48.8 | Arzneimittel (Biotechnologie) | USA | 10.0 Mrd. USD | - | - | 7.76 | 19.01 | ▲ 130.27% | ▲ 50.40% | - | - | - | -30.08% | ▲ 4364.50% | -31.31% | ▲ 4241.55% | -19.83% | ▲ 3814.23% | 3 / 9 | −0,99 | −19,9-fach | 72 / 100 | −7,8 / 100 | 0,59 |
![]() | Phibro Animal Health Corporation | 48.4 | Arzneimittel (Pharmazeutisch) | USA | 1.5 Mrd. USD | 15.42 | 155.89 | 1.01 | 3.99 | ▲ 12.74% | ▲ 12.89% | 1.23% | - | - | 6.57% | ▲ 0.31% | 13.07% | ▲ 1.06% | 0.65% | ▲ 0.96% | 6 / 9 | 4,66 | 3-fach | 34 / 100 | 2,1 / 100 | −2,31 |
![]() | Novavax Inc | 48.4 | Arzneimittel (Biotechnologie) | USA | 1.7 Mrd. USD | - | - | 4.11 | -8.93 | ▲ 18.76% | - | - | - | - | 39.19% | ▲ 39.63% | 50.14% | ▲ 39.84% | -22.27% | ▼ -7.37% | 6 / 9 | −7,22 | −3,8-fach | 89 / 100 | 58,2 / 100 | 0,66 |
![]() | Harrow Health Inc | 48.0 | Arzneimittel (Pharmazeutisch) | USA | 1.1 Mrd. USD | - | 207.96 | 4.00 | 72.48 | ▲ 40.99% | ▲ 8.89% | - | - | - | -1.89% | ▲ 5.31% | 14.18% | ▲ 2.62% | 15.70% | ▲ 7.24% | 6 / 9 | 1,15 | 0-fach | 51 / 100 | −12,3 / 100 | −3,04 |
![]() | SIGA Technologies Inc | 47.2 | Arzneimittel (Pharmazeutisch) | USA | 0.2 Mrd. USD | - | - | 4.43 | 1.44 | ▼ -5.41% | ▼ -16.19% | - | - | - | 24.63% | ▼ -4.26% | 25.05% | ▼ -7.13% | 45.58% | ▲ 7.16% | 6 / 9 | 16,23 | unbegrenzt | 30 / 100 | −9,2 / 100 | −4,02 |
![]() | Biogen Inc | 46.5 | Arzneimittel (Biotechnologie) | USA | 36.1 Mrd. USD | 103.62 | 17.41 | 3.50 | 1.91 | ▼ -6.11% | ▼ -20.22% | - | - | - | 13.18% | ▼ -1.51% | 19.14% | ▼ -1.52% | 20.90% | ▼ -0.44% | 5 / 9 | 5,62 | 7-fach | 23 / 100 | −3,1 / 100 | −2,49 |
![]() | Prestige Brand Holdings Inc | 43.6 | Arzneimittel (Pharmazeutisch) | USA | 2.3 Mrd. USD | 13.43 | 9.81 | 2.09 | 1.20 | ▲ 2.91% | ▲ 2.93% | - | - | - | 17.48% | ▲ 2.33% | 28.42% | ▲ 2.77% | 22.64% | ▲ 0.09% | 5 / 9 | 3,94 | 6-fach | 16 / 100 | −1,9 / 100 | −2,25 |
![]() | Beam Therapeutics Inc | 41.8 | Arzneimittel (Biotechnologie) | USA | 3.0 Mrd. USD | - | - | 19.05 | 2.78 | ▲ 466.27% | ▼ -16.29% | - | - | - | -57.24% | ▲ 114.93% | -274.57% | ▲ 86.62% | -257.65% | ▼ -59.65% | 5 / 9 | 6,77 | −3,2-fach | 8 / 100 | 17,9 / 100 | - |
![]() | CytomX Therapeutics Inc | 41.7 | Arzneimittel (Biotechnologie) | USA | 0.5 Mrd. USD | - | - | 28.10 | 1.70 | ▲ 2.18% | ▼ -11.99% | - | - | - | -22.79% | ▲ 39.23% | -29.35% | ▲ 39.09% | -99.48% | ▲ 29.68% | 2 / 9 | −9,88 | unbegrenzt | 50 / 100 | 38,4 / 100 | −0,96 |
![]() | Ironwood Pharmaceuticals Inc | 41.4 | Arzneimittel (Biotechnologie) | USA | 0.6 Mrd. USD | 4.59 | 3.21 | 1.53 | -3.69 | ▼ -5.33% | ▼ -25.72% | - | - | - | 8.11% | ▼ -28.16% | 40.10% | ▼ -6.65% | 42.89% | ▼ -7.79% | 7 / 9 | −11,90 | −8,3-fach | 75 / 100 | −26,0 / 100 | −5,72 |
![]() | Mirum Pharmaceuticals Inc | 40.6 | Arzneimittel (Biotechnologie) | USA | 5.6 Mrd. USD | - | - | 9.01 | -534.62 | ▲ 116.34% | ▼ -25.71% | - | - | - | -4.48% | ▲ 101.87% | -4.25% | ▲ 194.80% | 10.53% | ▲ 176.63% | 6 / 9 | 0,66 | −5,2-fach | 50 / 100 | −9,4 / 100 | −2,58 |
![]() | Crinetics Pharmaceuticals Inc | 39.0 | Arzneimittel (Biotechnologie) | USA | 9.0 Mrd. USD | - | - | 213.80 | 7.56 | ▲ 155.27% | ▲ 44.89% | - | - | - | -6046.22% | ▼ -1763.70% | -6714.77% | ▼ -2251.71% | -4985.50% | ▼ -1310.63% | 4 / 9 | 6,01 | - | 1 / 100 | −7,7 / 100 | 5,52 |
![]() | Assembly Biosciences Inc | 39.0 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 5.60 | 1.37 | ▲ 35.27% | ▼ -42.53% | - | - | - | -8.47% | ▲ 207.57% | -16.76% | ▲ 209.26% | -56.93% | ▲ 141.45% | 5 / 9 | −1,18 | - | 28 / 100 | 13,6 / 100 | −1,52 |
![]() | Immunome Inc | 38.9 | Arzneimittel (Biotechnologie) | USA | 2.2 Mrd. USD | - | - | 175.85 | 8.22 | - | - | - | - | - | -3059.99% | - | -3084.76% | - | -2890.13% | - | 4 / 9 | 13,99 | - | 1 / 100 | −3,1 / 100 | - |
![]() | Zevra Therapeutics Inc. | 38.5 | Arzneimittel (Biotechnologie) | USA | 0.6 Mrd. USD | 10.56 | 18.89 | 4.52 | 2.83 | ▲ 51.62% | - | - | - | - | 78.17% | ▲ 3.27% | -3.98% | ▼ -1.15% | -2.29% | ▼ -18.67% | 6 / 9 | 2,88 | −1,9-fach | 32 / 100 | 29,8 / 100 | 1,47 |
![]() | UroGen Pharma Ltd | 38.4 | Arzneimittel (Biotechnologie) | USA | 1.6 Mrd. USD | - | - | 8.74 | -12.46 | ▲ 56.22% | ▲ 3.62% | - | - | - | -139.81% | ▲ 21.20% | -113.73% | ▲ 17.25% | -148.22% | ▲ 8.92% | 2 / 9 | −15,41 | −5,2-fach | 49 / 100 | 4,5 / 100 | −1,77 |
![]() | Wave Life Sciences Ltd | 38.0 | Arzneimittel (Pharmazeutisch) | USA | 0.7 Mrd. USD | - | - | 10.12 | 1.79 | ▲ 16.31% | ▲ 6.39% | - | - | - | -478.33% | ▲ 398.53% | -504.09% | ▲ 396.93% | -440.50% | ▲ 295.50% | 3 / 9 | 1,34 | - | 5 / 100 | −2,6 / 100 | −2,25 |
![]() | Syndax Pharmaceuticals Inc | 37.9 | Arzneimittel (Biotechnologie) | USA | 1.3 Mrd. USD | - | - | 5.04 | 84.04 | ▲ 157.68% | ▲ 38.53% | - | - | - | -165.60% | ▲ 793.82% | -158.45% | ▲ 764.63% | -187.50% | ▲ 785.52% | 3 / 9 | −7,27 | −17,0-fach | 31 / 100 | 7,1 / 100 | 2,72 |
![]() | Arvinas Inc | 37.9 | Arzneimittel (Pharmazeutisch) | USA | 0.5 Mrd. USD | 53.43 | - | 1.57 | 0.88 | ▲ 64.50% | ▼ -6.29% | - | - | - | -30.77% | ▲ 85.45% | -43.75% | ▲ 85.42% | -104.99% | ▼ -247.14% | 5 / 9 | −1,37 | - | 36 / 100 | 26,9 / 100 | −1,72 |
| Inhibrx Biosciences, Inc. | 37.6 | Arzneimittel (Biotechnologie) | USA | 1.1 Mrd. USD | - | - | 770.47 | 15.73 | ▼ -36.72% | ▲ 12.97% | - | - | - | -10773.46% | ▲ 83115.96% | -10386.54% | ▼ -17845.46% | -9986.54% | ▼ -11090.58% | 4 / 9 | −6,85 | 24-fach | −1 / 100 | −7,0 / 100 | 1,28 | |
| Avalo Therapeutics Inc | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 6471.96 | 4.60 | ▼ -61.19% | ▲ 4.27% | - | - | - | -132642.37% | ▼ -26989.35% | -123601.69% | ▼ -25948.85% | -87216.95% | ▼ -18277.82% | 3 / 9 | −9,25 | −17,6-fach | 0 / 100 | −23,0 / 100 | −6,78 | |
| CAMP4 THERAPEUTICS CORPORATION | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | - | 54.33 | -330.52 | ▼ -59.18% | ▲ 7.38% | - | - | - | -2298.54% | ▼ -1251.06% | -1488.31% | ▼ -1110.15% | -852.83% | ▼ -873.51% | 4 / 9 | −6,47 | −37,9-fach | 2 / 100 | −43,2 / 100 | −1,02 | |
![]() | Ardelyx Inc | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.8 Mrd. USD | - | - | 1.78 | 5.37 | ▲ 121.90% | ▼ -8.17% | - | - | - | -15.12% | ▲ 321.98% | -10.06% | ▲ 315.10% | -10.80% | ▲ 315.78% | 3 / 9 | −2,22 | −1,9-fach | 73 / 100 | −3,8 / 100 | −2,34 |